These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28645757)

  • 1. Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study.
    Hopper I; Gronda E; Hoppe UC; Rundqvist B; Marwick TH; Shetty S; Hayward C; Lambert T; Hering D; Esler M; Schlaich M; Walton A; Airoldi F; Brandt MC; Cohen SA; Reiters P; Krum H
    J Card Fail; 2017 Sep; 23(9):702-707. PubMed ID: 28645757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: A Prospective, Randomized, Controlled, Pilot Study.
    Chen W; Ling Z; Xu Y; Liu Z; Su L; Du H; Xiao P; Lan X; Shan Q; Yin Y
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E153-E161. PubMed ID: 27143319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Renal Sympathetic Denervation in Patients with Early-Stage Heart Failure Versus Late-Stage Heart Failure.
    Geng J; Chen C; Zhou X; Qian W; Shan Q
    Int Heart J; 2018 Jan; 59(1):99-104. PubMed ID: 29279521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of percutaneous renal sympathetic denervation on cardiac function and exercise tolerance in patients with chronic heart failure.
    Gao JQ; Xie Y; Yang W; Zheng JP; Liu ZJ
    Rev Port Cardiol; 2017 Jan; 36(1):45-51. PubMed ID: 27988231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    Li M; Ma W; Fan F; Yi T; Qiu L; Wang Z; Weng H; Zhang Y; Li J; Huo Y
    J Cardiol; 2023 Jun; 81(6):513-521. PubMed ID: 36758670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous renal artery denervation in patients with chronic systolic heart failure: A randomized controlled trial.
    Gao JQ; Yang W; Liu ZJ
    Cardiol J; 2019; 26(5):503-510. PubMed ID: 29611171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Sympathetic Denervation Improves Outcomes in a Canine Myocardial Infarction Model.
    Nasi-Er BG; Lou X; Zhang Y; Sun H; Zhou X; Li Y; Zhou Q; Zhang J; Tang B; Lu Y
    Med Sci Monit; 2019 May; 25():3887-3893. PubMed ID: 31127792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure.
    Booth LC; Schlaich MP; Nishi EE; Yao ST; Xu J; Ramchandra R; Lambert GW; May CN
    Int J Cardiol; 2015; 190():220-6. PubMed ID: 25920032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a systematic review and meta-analysis.
    Fukuta H; Goto T; Wakami K; Ohte N
    Heart Fail Rev; 2017 Nov; 22(6):657-664. PubMed ID: 28646466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney.
    Polhemus DJ; Trivedi RK; Gao J; Li Z; Scarborough AL; Goodchild TT; Varner KJ; Xia H; Smart FW; Kapusta DR; Lefer DJ
    J Am Coll Cardiol; 2017 Oct; 70(17):2139-2153. PubMed ID: 29050562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Renal Sympathetic Denervation on Dogs with Pressure Overload-Induced Heart Failure.
    Chen P; Leng S; Luo Y; Li S; Huang Z; Liu Z; Liu Z; Wang J; Lei X
    Heart Lung Circ; 2017 Feb; 26(2):194-200. PubMed ID: 27555054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal denervation on kidney function in patients with chronic kidney disease.
    Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
    Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study.
    Zipes DP; Neuzil P; Theres H; Caraway D; Mann DL; Mannheimer C; Van Buren P; Linde C; Linderoth B; Kueffer F; Sarazin SA; DeJongste MJL;
    JACC Heart Fail; 2016 Feb; 4(2):129-136. PubMed ID: 26682789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Renal Denervation on Cardiac Function and Inflammatory Factors in Heart Failure After Myocardial Infarction.
    Li C; Xia W; Wang L; Zhang J; He Q; Liu Y; Xia D; Lu C
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):602-609. PubMed ID: 32868626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
    J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry.
    Ukena C; Mahfoud F; Ewen S; Bollmann A; Hindricks G; Hoffmann BA; Linz D; Musat D; Pavlicek V; Scholz E; Thomas D; Willems S; Böhm M; Steinberg JS
    Clin Res Cardiol; 2016 Oct; 105(10):873-9. PubMed ID: 27364940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrillatory effects of renal denervation on ventricular fibrillation in a canine model of pacing-induced heart failure.
    Luo Q; Jin Q; Zhang N; Huang S; Han Y; Lin C; Ling T; Chen K; Pan W; Wu L
    Exp Physiol; 2018 Jan; 103(1):19-30. PubMed ID: 29094471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.